Trial NCT03685344

View at ClinicalTrials.gov 
Org. Study IDs: ADCT-402-104
Secondary IDs: 2018-002670-43

Last trial update was posted on 2021-10-26

MeSH Interventions

Antibodies, Monoclonal Durvalumab Loncastuximab tesirine

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell

Other Conditions

Diffuse Large B-Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma

Stopping Reasons

In a limited number of patients, no additional activity was evident for the combination vs. loncastuximab tesirine monotherapy.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID